Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Small Cell Lung Carcinoma 30Burkitt Lymphoma 12Lung Neoplasms 11Leukemia, Myeloid, Acute 11Recurrence 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Large B-Cell, Diffuse 8Lymphoma, Non-Hodgkin 7Hodgkin Disease 7Carcinoma, Non-Small-Cell Lung 7Neuroblastoma 4Lymphoma, B-Cell 4Leukemia 4Wilms Tumor 3Sarcoma, Ewing 3Plasmablastic Lymphoma 3Neoplasms, Germ Cell and Embryonal 3Neoplasms 3Myelodysplastic Syndromes 3Multiple Myeloma 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, T-Cell 3Lymphoma, Mantle-Cell 3Lymphoma, Follicular 3Immunoblastic Lymphadenopathy 3Ganglioneuroblastoma 3Teratoma 2Sarcoma 2

Interventions

prednylidene 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1ibrutinib 1deltacortene 1Vincristine 1Rituximab 1Prednisone 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Doxorubicin 1Cyclophosphamide 1CT-P10 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, AIDS-Related × Etoposide × 90 days × Clear all
NCT03220022 2026-04-13

Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas

National Cancer Institute (NCI)

Phase 1 Active not recruiting
46 enrolled 19 charts
Lymphoid

Lymphoma, AIDS-Related

Data powered by HemOnc (CC BY 4.0) Colophon âš¡